Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Change in Cash: 2015-2024

Historic Change in Cash for Rhythm Pharmaceuticals (RYTM) over the last 10 years, with Dec 2024 value amounting to $29.2 million.

  • Rhythm Pharmaceuticals' Change in Cash rose 26.97% to -$83.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year increase of 128.14%. This contributed to the annual value of $29.2 million for FY2024, which is 143.19% up from last year.
  • As of FY2024, Rhythm Pharmaceuticals' Change in Cash stood at $29.2 million, which was up 143.19% from -$67.6 million recorded in FY2023.
  • Over the past 5 years, Rhythm Pharmaceuticals' Change in Cash peaked at $68.4 million during FY2022, and registered a low of -$67.6 million during FY2023.
  • Moreover, its 3-year median value for Change in Cash was $29.2 million (2024), whereas its average is $10.0 million.
  • Per our database at Business Quant, Rhythm Pharmaceuticals' Change in Cash crashed by 208.09% in 2021 and then surged by 264.17% in 2022.
  • Rhythm Pharmaceuticals' Change in Cash (Yearly) stood at $38.6 million in 2020, then tumbled by 208.09% to -$41.7 million in 2021, then spiked by 264.17% to $68.4 million in 2022, then plummeted by 198.78% to -$67.6 million in 2023, then surged by 143.19% to $29.2 million in 2024.